CDC headquarters in Atlanta
Elijah Nouvelage | Bloomberg through Getty Pictures
A key U.S. Facilities for Illness Management and Prevention panel voted unanimously to suggest Pfizer-BioNTech’s Covid-19 vaccine for folks 16 years and older on Saturday, clearing one other pivotal hurdle for the drug earlier than vaccinations start within the coming days.
The CDC’s Advisory Committee on Immunization Practices, an outdoor group of medical consultants that advises the company, voted 11 to 0 suggest the vaccine to be used in folks 16 and older underneath the Meals and Drug Administrations emergency authorization. Three members recused themselves as a consequence of conflicts.
On Dec. 1, the group voted 13-1 to present health-care staff and long-term care facility residents the primary vaccine doses as soon as cleared for public use. The ACIP’s emergency assembly, which was pushed from Sunday to Saturday, adopted the FDA’s resolution to situation Pfizer’s vaccine an emergency use authorization Friday night.
This can be a growing story. Please verify again later for updates.